GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Moolec Science MLEC · USD

Consumer Staples · US listing · 🇺🇸 United States

Compare

0.85

-39.29%

Close of 2 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Moolec Science

Its shares trade under the ticker MLEC. It has been listed since 3 January 2023. In the fiscal year to 30 June 2025, it reported revenue of $333.6m and a net loss of $111.5m. At that date it held total assets of $204.7m and shareholders' equity of −$66.0m.

Moolec Science SA operates as a science-based ingredient company. The firm focuses on developing real animal proteins in plants using Molecular Farming, which is a sustainable technology. The company operates in the United States, Europe, and South America. The firm's technology allows it to include animal proteins' gene deoxyribonucleic acid (DNA) codes inside the genome of the main plants used in food. Each protein is selected to add value in terms of targeted functionality, such as taste, texture, and nutritional values.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Consumer Staples
Industry
Food Products
Listed since
3 Jan 2023
Employees
103
Head office
89 NEXUS WAY, CAMANA BAY, GRAND CAYMAN, KY1-9009
Incorporated in
E9
Classification
Food and Kindred Products
Filer status
Non-accelerated filer<br>Emerging growth company

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Moolec Science SA develops real animal proteins in plants using Molecular Farming technology.
  • The company operates in the United States, Europe, and South America markets.
  • Moolec Science SA's technology integrates animal protein DNA codes into plant genomes for targeted functionality.

Weaknesses

  • Moolec Science SA has 103 employees, which may limit scalability.
  • The company is listed on 3 January 2023, indicating a relatively new market presence.
  • Moolec Science SA focuses on Consumer Staples sector with limited diversification.

Opportunities

  • Expanding into new markets like South America for plant-based protein solutions.
  • Growing demand for sustainable food products in Europe and the United States.
  • Increasing adoption of Molecular Farming technology in the Food Products industry.

Threats

  • Competition from established food companies in the Consumer Staples sector.
  • Regulatory challenges in introducing genetically modified plant proteins.
  • Economic downturns affecting consumer spending on premium food products.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.